Status:
TERMINATED
Efficacy of Valproate in Peripheral Neuropathic Pain
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Sanofi-Synthelabo
Conditions:
Neuralgia
Neuropathic Peripheral Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine whether valproate is effective and well tolerated in the treatment of neuropathic peripheral pain. The drug is administered by intravenous route followed by o...
Detailed Description
Background. Neuropathic peripheral pain is often refractory to usual analgesics. Some anticonvulsant drugs may be effective, but often partially only, and not always well tolerated. Valproate is a wel...
Eligibility Criteria
Inclusion
- peripheral neuropathic pain
- signed written informed consent
Exclusion
- central neuropathic pain
- current or past hepatic disease
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2005
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00221637
Start Date
March 1 2002
End Date
July 1 2005
Last Update
June 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unité de traitement de la douleur chronique, Hôpital Pellegrin, CHU de Bordeaux
Bordeaux, France, 33076